1st International Workshop on Future Therapies in Autoimmune Hepatitis

AIH Workshop gruppenbild
Back to overview

Friutfull 1st International Workshop on Future Therapies in Autoimmune Hepatitis with experts from various different scientific fields. The outstanding success of this workshop was the cooperation not only of clinicians but also of biostatisticians, patient advocates and medical officers from the FDA.

On 1 + 2 June international experts were invited to attend the 1st International Workshop on Future Therapies in Autoimmune Hepatitis (AIH), taking place in Hamburg, Germany. The workshop focused on updates on current therapeutic strategies for autoimmune hepatitis, the clinical need for new therapeutic approaches, ongoing and future clinical trials, patient-reported outcomes & Quality of Life under treatment and a concluding session regarding the conceptual design of a multicenter randomized controlled trial in autoimmune hepatitis.

International experts were invited to attend the 1st International Workshop on Future Therapies in Autoimmune Hepatitis (AIH), taking place in Hamburg, Germany on June 1-2, 2023. The workshop focussed on updates on current therapeutic strategies for autoimmune hepatitis, the clinical need for new therapeutic approaches, ongoing and future clinical trials, patient-reported outcomes & quality of life under treatment and a concluding session regarding the conceptual design of a multicenter randomized controlled trial in autoimmune hepatitis.

The workshop was attended by a diverse group of international experts in the field, including clinicians, scientists, and medical statisticians. The conjoined expertise of international experts will bring together a broad range of skills necessary to develop new treatment strategies for AIH. It will enable participants to share knowledge, collaborate, and ultimately improve the lives of patients with autoimmune hepatitis.

AIH as a rare liver disease is a growing clinical concern with rising prevalence and limited therapeutic evidence. While current treatment regimens are effective for many patients, there is still a need for new therapeutic approaches with fewer side effects than classical steroid-based treatment. A central element of the workshop will be a session on the conceptual design of a multicenter randomized controlled trial in autoimmune hepatitis. This trial will be a collaborative effort between experts from around the world and will aim to improve our understanding of the disease and develop new treatment options.